Literature DB >> 23381819

Validation of protocol of experimental necrotizing enterocolitis in rats and the pitfalls during the procedure.

Frances Lilian Lanhellas Gonçalves1, Rodrigo Melo Gallindo, Lucas Manoel Mangueira Soares, Rebeca Lopes Figueira, Fábio Antônio Perecim Volpe, Maurício André Pereira-da-Silva, Lourenço Sbragia.   

Abstract

PURPOSE: To describe the difficulties of implementing the protocol of experimental necrotizing enterocolitis (NEC) in order to obtain a larger number of newborns affected with the disease and a lower mortality.
METHODS: Term Sprague-Dawley newborns rats (22 days) were divided into four groups of 12 fetuses each (n = 48): EC--breastfed newborns; IH--breastfed newborns and subjected to a stress protocol by ischemia and hypothermia; ESB--formula-fed newborns (Esbilac®, PetAg, Hampshire, IL, USA) and NEC--formula-fed newborns and subjected to stress protocol. The parameters set for the study protocol were: milk concentration (0.19 g ml or 0.34 g/ml), diet instilled volume (according to body weight--200 kcal/day/Kg--or progressive, according to acceptance), weight (gain, loss or maintenance) and duration of the experiment (72 hours or 96 hours). Data of body weight (BW), intestinal weight (IW) and the IW/BW ratio were obtained. Samples of terminal ileum were collected and analyzed by the degree of injury to the intestinal wall. Statistically significance was set to p<0.05.
RESULTS: The established protocol with less mortality and increased number of NEC was with Esbilac® at a concentration of 0.19 g/ml of diet instilled volume of 0.1 ml, every 3 hours, for 72 hours. All infants fed with artificial milk lost weight. In the degree score of intestinal injury, the ESB, IH and NEC groups were considered positive for NEC with greater histological injury in the latter.
CONCLUSION: The described NEC protocol in rats allowed a greater survival of puppies with a greater number of animals affected by the disease.

Entities:  

Mesh:

Year:  2013        PMID: 23381819     DOI: 10.1590/s0102-86502013001300005

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  3 in total

1.  Use of sildenafil and L-arginine in an experimental rat model for the prevention of neonatal necrotizing enterocolitis.

Authors:  Gabriela Araujo Moreira; André Ivan Bradley Dos Santos Dias; Silvia Maria Suter Correia Cadena; Marília Locatelli Corrêa-Ferreira; Sergio Ossamu Ioshii; Camila Girardi Fachin
Journal:  Sci Rep       Date:  2022-04-13       Impact factor: 4.379

2.  Human placental-derived stem cell therapy ameliorates experimental necrotizing enterocolitis.

Authors:  Victoria G Weis; Anna C Deal; Gehad Mekkey; Cara Clouse; Michaela Gaffley; Emily Whitaker; Cole B Peeler; Jared A Weis; Marshall Z Schwartz; Anthony Atala
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-02-10       Impact factor: 4.052

3.  Temporal profile of intestinal tissue expression of intestinal fatty acid-binding protein in a rat model of necrotizing enterocolitis.

Authors:  Ana Leda Bertoncini Simões; Rebeca Lopes Figueira; Frances Lilian Lanhellas Gonçalves; Luís Felipe Tsuyoshi Mitidiero; Orlando Castro E Silva; José Luis Peiró; Lourenço Sbragia
Journal:  Clinics (Sao Paulo)       Date:  2016-07       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.